Janine C. Bestall - Publications

Non-medicinal oral contrast in upper abdominal MRI for MR-guided radiotherapy: A scoping review.

Journal: Radiography (London, England : 1995)

Published: October 10, 2024

Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Journal: Health technology assessment (Winchester, England)

Published: September 09, 2024

PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 19, 2024

The Prehabilitation Radiotherapy Exercise, smoking Habit cessation and Balanced diet Study (PREHABS) protocol to explore the feasibility of embedding behavioural modifications into the clinical pathway for patients undergoing radical radiotherapy for lung cancer.

Journal: BMJ open

Published: January 25, 2024

Integrating the patients' voice in designing and delivering a research study: The Yorkshire Cancer Research funded PREHABS study's experience.

Journal: Radiography (London, England : 1995)

Published: December 05, 2022

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

Journal: The Lancet. Oncology

Published: November 02, 2022

Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: June 13, 2022

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.

Journal: BMC cancer

Published: January 09, 2021

SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection.

Journal: The European respiratory journal

Published: January 20, 2020

New models of care: a liaison psychiatry service for medically unexplained symptoms and frequent attenders in primary care.

Journal: BJPsych bulletin

Published: December 14, 2017

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

Journal: Pilot and feasibility studies

Published: December 16, 2016

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

Journal: Pilot and feasibility studies

Published: October 21, 2015